MX9301732A - Derivados de chitosan n-substituidos, procedimiento para su preparacion y uso de los mismos. - Google Patents

Derivados de chitosan n-substituidos, procedimiento para su preparacion y uso de los mismos.

Info

Publication number
MX9301732A
MX9301732A MX9301732A MX9301732A MX9301732A MX 9301732 A MX9301732 A MX 9301732A MX 9301732 A MX9301732 A MX 9301732A MX 9301732 A MX9301732 A MX 9301732A MX 9301732 A MX9301732 A MX 9301732A
Authority
MX
Mexico
Prior art keywords
structural elements
alkyl
co2h
alkoxy
chitosan
Prior art date
Application number
MX9301732A
Other languages
English (en)
Inventor
Dieter Lohmann
Donald Richard Randell
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of MX9301732A publication Critical patent/MX9301732A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0024Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
    • C08B37/00272-Acetamido-2-deoxy-beta-glucans; Derivatives thereof
    • C08B37/003Chitin, i.e. 2-acetamido-2-deoxy-(beta-1,4)-D-glucan or N-acetyl-beta-1,4-D-glucosamine; Chitosan, i.e. deacetylated product of chitin or (beta-1,4)-D-glucosamine; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/736Chitin; Chitosan; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J5/00Manufacture of articles or shaped materials containing macromolecular substances
    • C08J5/18Manufacture of films or sheets
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00Anti-perspirants or body deodorants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2305/00Characterised by the use of polysaccharides or of their derivatives not provided for in groups C08J2301/00 or C08J2303/00
    • C08J2305/08Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Materials Engineering (AREA)
  • Manufacturing & Machinery (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Birds (AREA)
  • Inorganic Chemistry (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Cosmetics (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)

Abstract

Derivados de chitosán que tienen unidades estructurales de la fórmula I, II y III, en una distribución aleatoria y los ésteres y derivados de los mismos, cuyos derivados de chitosán contienen un total de cuando menos dos unidades estructurales, y, basándose en un mol del derivado de chitosán, del 30 al 100 por ciento molar de unidades estructurales de la fórmula I, del 60 al 0 por ciento molar de unidades estructurales de la fórmula II, y del 30 al 0 por ciento molar de unidades estructurales de la fórmula III, y la suma de los procentajes molares es el 100 por ciento. Estos derivados son adecuados para utilizarse como humectantes y para la prevención de la adherencia a, y/o formación de, depósitos sólidos sobre substratos inorgánicos u orgánicos.
MX9301732A 1992-03-27 1993-03-26 Derivados de chitosan n-substituidos, procedimiento para su preparacion y uso de los mismos. MX9301732A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH98192 1992-03-27

Publications (1)

Publication Number Publication Date
MX9301732A true MX9301732A (es) 1994-01-31

Family

ID=4199699

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9301732A MX9301732A (es) 1992-03-27 1993-03-26 Derivados de chitosan n-substituidos, procedimiento para su preparacion y uso de los mismos.

Country Status (9)

Country Link
EP (1) EP0563013B1 (es)
JP (1) JPH0641202A (es)
KR (1) KR100257092B1 (es)
AT (1) ATE152132T1 (es)
AU (1) AU658986B2 (es)
BR (1) BR9301334A (es)
CA (1) CA2092513A1 (es)
DE (1) DE59306229D1 (es)
MX (1) MX9301732A (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0628655B1 (de) * 1993-06-11 2001-05-16 Ciba SC Holding AG Bleichhilfsmittel
IL115670A (en) * 1994-10-21 1999-11-30 Nihon Mediphysics Co Ltd Diagnostic imaging agent
EP0718313B1 (de) * 1994-12-22 2000-10-11 Ciba SC Holding AG N-cyanomethylierte Chitosane und deren Hydrolyseprodukte
KR100348804B1 (ko) * 1998-12-07 2002-11-18 주식회사 태평양 키토산글루코노델타락톤염및이염을이용하여올리고키토산을제조하는방법
GB0221941D0 (en) 2002-09-20 2002-10-30 Univ Strathclyde Polysoaps
EP1440683A1 (de) * 2003-01-23 2004-07-28 Cognis France S.A. Verwendung von Oligoglucosaminen in kosmetischen oder dermatologischen Zubereitungen
US7390579B2 (en) 2003-11-25 2008-06-24 Magnequench, Inc. Coating formulation and application of organic passivation layer onto iron-based rare earth powders
JP5522615B2 (ja) * 2006-09-15 2014-06-18 国立大学法人 宮崎大学 貴金属イオン捕集剤として有用なポリマー
EP1955710A1 (en) * 2007-02-09 2008-08-13 The Jordanian Pharmaceutical Manufacturing Co. Aqueous composition comprising chitosan and an acidic drug
EP2197555B1 (en) 2007-05-07 2015-12-02 Koninklijke Philips N.V. A method for cleaning dental plaque from teeth using an adherent peelable gel
WO2023149402A1 (ja) * 2022-02-03 2023-08-10 東ソー株式会社 水溶性キレートポリマー及びその製造方法
CN116813985B (zh) * 2023-07-14 2024-02-09 唐山学院 一种用于硫化氢气体的预警材料及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU419529A1 (es) * 1971-03-26 1974-03-15
US3953608A (en) * 1971-05-10 1976-04-27 L'oreal Cosmetic compositions for the skin containing a chitosan derivative
US3879376A (en) * 1971-05-10 1975-04-22 Oreal Chitosan derivative, method of making the same and cosmetic composition containing the same
DE3432227A1 (de) * 1984-09-01 1986-03-13 Wella Ag, 6100 Darmstadt Sulfopropylderivate des chitins und chitosans, verfahren zu ihrer herstellung sowie ihre verwendung

Also Published As

Publication number Publication date
BR9301334A (pt) 1993-10-05
EP0563013B1 (de) 1997-04-23
AU3551193A (en) 1993-09-30
KR100257092B1 (ko) 2000-08-01
CA2092513A1 (en) 1993-09-28
KR930019700A (ko) 1993-10-18
JPH0641202A (ja) 1994-02-15
AU658986B2 (en) 1995-05-04
EP0563013A2 (de) 1993-09-29
DE59306229D1 (de) 1997-05-28
ATE152132T1 (de) 1997-05-15
EP0563013A3 (es) 1994-04-20

Similar Documents

Publication Publication Date Title
MX9301732A (es) Derivados de chitosan n-substituidos, procedimiento para su preparacion y uso de los mismos.
CA2053253A1 (en) New aryl-and heteroarylethenylene derivatives and process for their preparation
ES2115298T3 (es) Nuevos derivados de 1-fenil-3-dimetil-amino-propano, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
CA2205757A1 (en) Pyridazinone derivatives and their use as inhibitors of prostaglandin g/h synthase i and ii(cox i and ii)
DK1026147T3 (da) Forbindelser, der er anvendelige som mellemprodukter i fremstillingen af piperidinderivater
DK0622356T3 (da) Indoloylguanidinderivater som inhibitorer af natrium-hydrogen-udbytningen
MX9204622A (es) Nuevos derivados de 3,5-di-tert-butil-4-hidroxifenilo, procedimiento para su preparacion y composicion farmaceutica que los contiene.
DE69005164T2 (de) Acryloylsubstituierte Pyrrol-Derivate.
RS49503B (sr) Novi fenilamidin-derivati, postupak za njihovo pripremanje i njihova primena kao lekova
KR920701240A (ko) 글루타티온 유도체
UA43338C2 (uk) Похідні бензолу
MX9304709A (es) Derivados de tetrahidronaftaleno, su preparacion y su aplicacion en terapeutica.
PT83920B (pt) Processo para a preparacao de novos derivados de 4-morfolini-1h-indol e dos seus sais e de composicoes farmaceuticas que os contem
SE7813351L (sv) Substituerade 1,5-cyklohexadien-karboxylsyraderivat
DE69121961D1 (de) Flüssigkristallzusammensetzung und Anzeigevorrichtung, welche selbige verwendet
HU9702411D0 (en) Novel antiarrythmic compounds
IE45519L (en) Sulphur-containing n-(o-aminobenzyl)-amino acetic acids and¹esters.
IE44999L (en) Hydrazinopyridazine derivatives.
WO1992000740A3 (en) Bis-dioxopiperazines and their use as protection agents
DE69314929D1 (de) Benzolderivate
KR970027089A (ko) 신규 세팔로스포린 유도체 및 그 중간체

Legal Events

Date Code Title Description
FG Grant or registration
MM Annulment or lapse due to non-payment of fees